Posts about

Pressemeldung

Nachrichten der neuroCare Group

Hier finden Sie alle Nachrichten der neuroCare Group im Überblick. Um die Nachrichten nach Kategorien zu filtern, öffnen Sie die nachfolgende Liste.

Nachrichtenkategorien

Pressemeldung

21 Nov, 2022

neurocare group AG announces publication in International Journal of Clinical and Health Psychology confirming the importance of sleep for effectiveness of combined rTMS and CBT for OCD

Munich, November 21, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and

05 Sep, 2022

neurocare group AG expands international footprint with cooperation in the Middle East, the Republic of Ireland and Northern Ireland

Munich, Germany, September 5, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental

24 Aug, 2022

neurocare group AG and STIMIT AG announce strategic cooperation

Munich, Germany, August 23, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare group AG announces participation at Clinical TMS Society 2022 Annual Meeting

Munich, Germany, May 10, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare announces entry into ketamine-assisted therapy market through cooperation with Privatpraxis Dr. Scheib in Berlin

Munich, Germany, May 11, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare group AG announces recent start of a phase III trial examining the cost-effectiveness of TMS for patients with exposure therapy-resistant OCD

Munich, Germany, June 8, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare group AG announces TGA approval of Apollo TMS System with product launch at RANZCP Congress in Sydney

Munich, Germany, May 13, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare group AG continues expansion with opening of first UK clinic in London

Munich, Germany, June 14, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

14 Jul, 2022

neurocare group AG obtains patent grant on treatment method for neuromodulation in Japan

Munich, Germany, June 23, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health

28 Apr, 2022

neurocare group AG announces expansion of clinic network in the US

PRESS RELEASE Munich, April, 28, 2022 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental